SA PRO
Free Account
Sotera Health CompanySHCNASDAQ
LOADING
|||
Switch Symbol:
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 92% recommend buying.

Consensus Rating
Buy
12 analysts·Moderate coverage
92%
Rating Distribution
Strong Buy
00%
Buy
1192%
Hold
18%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 26% higher.

Bear Case
$20.00
+11%
Consensus
$22.67
+26%
Bull Case
$24.00
+33%
Price Range12 analysts
Low
Consensus
High
$20.00
$24.00
Current Target
Current Price
$18.06
Upside to Target
$4.61

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 9, 2026Piper Sandler
Sotera Health upgraded to Overweight from Neutral at Piper Sandler
Target:$24.00
+27.6%from $18.81
Jan 8, 2026RBC Capital
RBC Capital Starts Sotera Health (SHC) at Outperform
Target:$24.00
+27.6%from $18.81
Nov 5, 2025Piper Sandler
Sotera Health price target raised to $17 from $15 at Piper Sandler
Target:$17.00
+5.3%from $16.15
Nov 5, 2025Barclays
Sotera Health price target raised to $20 from $19 at Barclays
Target:$20.00
+21.7%from $16.43
Oct 2, 2025Barclays
Sotera Health price target raised to $19 from $17 at Barclays
Target:$19.00
+17.4%from $16.19
May 5, 2025Goldman Sachs
Sotera Health upgraded to Buy from Neutral at Goldman Sachs
Target:$17.00
+31.6%from $12.92
Dec 5, 2024Jefferies
Sotera Health (SHC) PT Lowered to $15 at Jefferies
Target:$15.00
+15.6%from $12.98
Nov 6, 2024Jefferies
Sotera Health (SHC) PT Raised to $18 at Jefferies
Target:$18.00
+17.9%from $15.27
Aug 6, 2024Barclays
Sotera Health price target raised to $17 from $14 at Barclays
Target:$17.00
+19.5%from $14.22
Jun 6, 2024Jefferies
Sotera Health (SHC) PT Raised to $14.50 at Jefferies
Target:$14.50
+21.0%from $11.98
May 21, 2024Piper Sandler
Piper Sandler Starts Sotera Health (SHC) at Neutral
Target:$13.00
+19.2%from $10.91
May 3, 2024RBC Capital
Sotera Health (SHC) PT Lowered to $17 at RBC Capital
Target:$17.00
+55.8%from $10.91
Apr 10, 2024Barclays
Sotera Health price target lowered to $14 from $19 at Barclays
Target:$14.00
+20.5%from $11.62
Mar 25, 2024Jefferies
Jefferies Upgrades Sotera Health (SHC) to Buy
Target:$15.50
+29.9%from $11.94
Jun 26, 2023Loop Capital Markets
Analyst Upgrades Sotera Health Shares To Overweight, Cites Strong Revenue Growth Outlook
Target:$24.00
+29.1%from $18.59
Jan 10, 2023Wolfe Research
Sotera Health upgraded to Outperform from Peer Perform at Wolfe Research
Target:$25.00
+44.9%from $17.25
Jan 10, 2023Barclays
Barclays Upgrades Sotera Health (SHC) to Overweight
Target:$22.00
+27.5%from $17.25
Nov 23, 2022Goldman Sachs
Goldman Sachs Maintains Neutral on Sotera Health, Lowers Price Target to $8
Target:$8.00
-1.4%from $8.12
Nov 15, 2022Barclays
Barclays Downgrades Sotera Health to Underweight, Lowers Price Target to $6
Target:$6.00
-15.9%from $7.13

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance